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phorus in the skin. We report here for the first time two
cases of calcinosis cutis following the local injection of
influenza vaccine.
A 51-year-old woman presented to our clinic with a 1-
year history of an asymptomatic subcutaneous mass over
the left deltoid area, which developed 6 months after an
intramuscular administration of the seasonal influenza
vaccine. No systemic symptoms such as fever, malaise,
myalgia, or loss of appetite were noted. On physical ex-
amination there was a subcutaneous induration at the in-
jection site (Fig. 1A). The histopathological examination
showed basophilic deposits of calcium material in the
subcutis (Fig. 1B). The laboratory examination was normal,
including serum calcium, phosphate, parathyroid hormone
level, and autoimmune blood tests.
A 56-year-old man presented with a painless, coin-sized
indurated plaque in the left deltoid region. This patient had
also received an intramuscular injection of seasonal influ-
enza vaccine 6 months earlier. Ultrasonography showed
echogenic foci with an acoustic shadow, which is the
diagnostic feature of calcification that differentiates it
from local inflammation (Fig. 1C). A biopsy sample of the
mass also indicated calcinosis cutis in the subcutaneous
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mune disease.
Influenza remains an important cause of morbidity and
mortality worldwide and therefore seasonal vaccination of
at-risk groups of patients is recommended each year by
health authorities in many countries. The most common
side effects of vaccination include soreness, erythema,
tenderness, or swelling at the injection site, headache,
fatigue, muscle ache, and malaise. Rare cutaneous adverse
reactions including exanthem, urticaria, vasculitis, ery-
thema multiforme, lichen planus, Sweet’s syndrome,
bullous fixed drug eruption, and linear immunoglobulin A
dermatosis have been documented to probably be induced
by influenza vaccination.1e4
Calcinosis cutis is classified into four major categories
according to different etiologies: dystrophic, metastatic,
iatrogenic, and idiopathic. Based on the localized lesions
without spreading and the normal laboratory data in these
two patients, we propose two possible mechanisms for the
development of calcinosis cutis following the administra-
tion of the seasonal influenza vaccine. Firstly, the calcinosis
cutis may be secondary to local trauma by an inappropriate
injection technique or an incorrect injection route, such as
dermal or subcutaneous. Secondly, the calcification could
have been iatrogenically induced by the calcium-containing
additives of the influenza vaccine. Calcium chloride is a
common approved additive in seasonal influenza vaccines
and has been reported to induce iatrogenic calcinosis cutis
by extravasation. In addition, calcium phosphate adjuvants
have been introduced to influenza vaccines for the induc-
tion of potent immunogenic responses.5 Thus we specu-
lated that calcium-containing influenza vaccines may have
a higher risk of inducing calcinosis cutis at the injection siteAssociation. All rights reserved.
Figure 1 (A) A subcutaneous induration is found at the injection site of the seasonal influenza vaccine on the left deltoid area of
a 51-year-old woman. (B) Histopathological examination shows basophilic deposits of calcium material in the subcutis (hemotoxylin
and eosin stain, 40). (C) Soft tissue sonography reveals features of calcification: echogenic foci with an acoustic shadow on the
left deltoid region of a 56-year-old man.
896 C.-H. Chiang, M.-H. Linthan calcium-free vaccines. Further clinical observations
and research are required to confirm this hypothesis.
In conclusion, we have described two cases of calcinosis
cutis at the deltoid injection site following the adminis-
tration of a seasonal influenza vaccine. Similar cases have
not been reported previously and may be underdiagnosed
because of the insidious onset. Medical ultrasonography is a
useful diagnostic tool to distinguish calcinosis cutis from
local inflammation before doctors take a skin biopsy sample
to confirm the diagnosis.
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